glycine has been researched along with Gastrointestinal Stromal Tumors in 2 studies
Gastrointestinal Stromal Tumors: All tumors in the GASTROINTESTINAL TRACT arising from mesenchymal cells (MESODERM) except those of smooth muscle cells (LEIOMYOMA) or Schwann cells (SCHWANNOMA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The majority of gastrointestinal stromal tumors (GISTs) are driven by oncogenic KIT signaling and can therefore be effectively treated with the tyrosine kinase inhibitor (TKI) imatinib mesylate." | 3.96 | Differential antitumor activity of compounds targeting the ubiquitin-proteasome machinery in gastrointestinal stromal tumor (GIST) cells. ( Agha, A; Ali, AA; Debiec-Rychter, M; Dhillon, HS; Duensing, A; Gebreyohannes, YK; Lee, DM; Makielski, KR; Mehalek, KR; Patil, SS; Rausch, JL; Schöffski, P; Tolstov, Y; Wellens, J; Wozniak, A, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rausch, JL | 1 |
| Ali, AA | 1 |
| Lee, DM | 1 |
| Gebreyohannes, YK | 1 |
| Mehalek, KR | 1 |
| Agha, A | 1 |
| Patil, SS | 1 |
| Tolstov, Y | 1 |
| Wellens, J | 1 |
| Dhillon, HS | 1 |
| Makielski, KR | 1 |
| Debiec-Rychter, M | 1 |
| Schöffski, P | 1 |
| Wozniak, A | 1 |
| Duensing, A | 1 |
| Serrano, C | 1 |
| Wang, Y | 1 |
| Mariño-Enríquez, A | 1 |
| Lee, JC | 1 |
| Ravegnini, G | 1 |
| Morgan, JA | 1 |
| Bertagnolli, MM | 1 |
| Beadling, C | 1 |
| Demetri, GD | 1 |
| Corless, CL | 1 |
| Heinrich, MC | 1 |
| Fletcher, JA | 1 |
2 other studies available for glycine and Gastrointestinal Stromal Tumors
| Article | Year |
|---|---|
Differential antitumor activity of compounds targeting the ubiquitin-proteasome machinery in gastrointestinal stromal tumor (GIST) cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Boron Compounds; Boronic Acids; Cell Line, Tumor; Drug Re | 2020 |
KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation.
Topics: Antineoplastic Agents; Arginine; Benzamides; Carcinoma; Drug Resistance, Neoplasm; Gastrointestinal | 2015 |